Tsutomu Suzuki

Q: What Schools Are Affiliated With Tsutomu Suzuki

Tsutomu Suzuki is affiliated with the following schools: Hoshi University, Shonan University of Medical Sciences

Tsutomu Suzuki's AcademicInfluence.com Rankings

Tsutomu Suzuki

Biology

#14816

World Rank

#18670

Historical Rank

Neuroscience

#2638

World Rank

#2708

Historical Rank

biology Degrees

Download Badge

Biology

Tsutomu Suzuki's Degrees

PhD Neuroscience University of Tokyo
Masters Biology University of Tokyo
Bachelors Biology University of Tokyo

Similar Degrees You Can Earn

Why Is Tsutomu Suzuki Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Tsutomu Suzuki's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine (2006) (490)
Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. (2005) (262)
Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala (2006) (254)
Hippocampal epigenetic modification at the brain‐derived neurotrophic factor gene induced by an enriched environment (2011) (181)
Direct Evidence of Astrocytic Modulation in the Development of Rewarding Effects Induced by Drugs of Abuse (2006) (159)
Blockade of morphine reward through the activation of κ-opioid receptors in mice (1993) (159)
Direct evidence for the involvement of brain‐derived neurotrophic factor in the development of a neuropathic pain‐like state in mice (2005) (154)
Suppression of the morphine‐induced rewarding effect in the rat with neuropathic pain: implication of the reduction in µ‐opioid receptor functions in the ventral tegmental area (2002) (137)
Usefulness of Antidepressants for Improving the Neuropathic Pain-Like State and Pain-Induced Anxiety through Actions at Different Brain Sites (2008) (134)
Direct evidence for spinal cord microglia in the development of a neuropathic pain‐like state in mice (2006) (123)
Direct Evidence for the Involvement of the Mesolimbic κ-Opioid System in the Morphine-Induced Rewarding Effect Under an Inflammatory Pain-Like State (2005) (118)
Epigenetic transcriptional activation of monocyte chemotactic protein 3 contributes to long-lasting neuropathic pain. (2013) (117)
Involvement of a spinal brain-derived neurotrophic factor/full-length TrkB pathway in the development of nerve injury-induced thermal hyperalgesia in mice (2002) (108)
Enhanced IL‐1β production in response to the activation of hippocampal glial cells impairs neurogenesis in aged mice (2010) (105)
Neuropathic and chronic pain stimuli downregulate central mu-opioid and dopaminergic transmission. (2010) (104)
Role of δ‐opioid receptor function in neurogenesis and neuroprotection (2006) (103)
Comparative Pharmacological Profiles of Morphine and Oxycodone under a Neuropathic Pain-Like State in Mice: Evidence for Less Sensitivity to Morphine (2008) (102)
Memory impairment associated with a dysfunction of the hippocampal cholinergic system induced by prenatal and neonatal exposures to bisphenol-A (2007) (93)
Change in MicroRNAs Associated with Neuronal Adaptive Responses in the Nucleus Accumbens under Neuropathic Pain (2011) (91)
Chronic pain‐induced emotional dysfunction is associated with astrogliosis due to cortical δ‐opioid receptor dysfunction (2006) (87)
Morphine-induced place preference in the CXBK mouse: characteristics of μ opioid receptor subtypes (1993) (85)
Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist (1999) (82)
Different roles of μ-, δ- and κ-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress (1999) (78)
Etonitazene delivered orally serves as a reinforcer for Lewis but not Fischer 344 rats (1992) (77)
Implication of Activated Astrocytes in the Development of Drug Dependence (2008) (75)
Effects of the histaminergic system on the morphine-induced conditioned place preference in mice (1995) (75)
Effects of a newly synthesized κ-opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats (2002) (72)
Mechanisms That Underlie μ-Opioid Receptor Agonist–Induced Constipation: Differential Involvement of μ-Opioid Receptor Sites and Responsible Regions (2013) (69)
Sleep disturbances in a neuropathic pain-like condition in the mouse are associated with altered GABAergic transmission in the cingulate cortex (2011) (68)
Protease-Activated Receptor-1 and Platelet-Derived Growth Factor in Spinal Cord Neurons Are Implicated in Neuropathic Pain after Nerve Injury (2005) (67)
Role of extracellular signal‐regulated kinase in the ventral tegmental area in the suppression of the morphine‐induced rewarding effect in mice with sciatic nerve ligation (2004) (67)
Involvement of Spinal Protein Kinase Cγ in the Attenuation of Opioid μ-Receptor-Mediated G-Protein Activation after Chronic Intrathecal Administration of [d-Ala2,N-MePhe4,Gly-Ol5]Enkephalin (2001) (66)
Regulation of inhibin production by rat granulosa cells (1987) (65)
Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats (2000) (64)
Long‐lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C‐dependent astrocytic response and behavioral sensitization (2005) (64)
Glutamatergic neurotransmission and protein kinase C play a role in neuron–glia communication during the development of methamphetamine‐induced psychological dependence (2005) (62)
Enhanced μ-Opioid Responses in the Spinal Cord of Mice Lacking Protein Kinase Cγ Isoform* (2001) (60)
Molecular Evidence for the Functional Role of Dopamine D3 Receptor in the Morphine-Induced Rewarding Effect and Hyperlocomotion (2003) (60)
Implication of protein kinase C in the orexin‐induced elevation of extracellular dopamine levels and its rewarding effect (2007) (60)
The Astrocyte-Targeted Therapy by Bushi for the Neuropathic Pain in Mice (2011) (60)
Effects of differential modulation of μ-, δ- and κ-opioid systems on bicuculline-induced convulsions in the mouse (2000) (58)
Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models. (2009) (58)
Role of delta-opioid receptor function in neurogenesis and neuroprotection. (2006) (58)
Change in the expression of c-fos in the rat brain following sciatic nerve ligation (2003) (58)
Neuronal protein kinase Cγ‐dependent proliferation and hypertrophy of spinal cord astrocytes following repeated in vivo administration of morphine (2004) (56)
Role of central ATP-sensitive potassium channels in the analgesic effect and spinal noradrenaline turnover-enhancing effect of intracerebroventricularly injected morphine in mice (1992) (55)
Effect of repeated administration of morphine on the activity of extracellular signal regulated kinase in the mouse brain (2002) (54)
Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine‐induced rewarding effect in mice (2004) (52)
Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines (2005) (51)
Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice (2003) (51)
MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: A novel dual-acting μ- and κ-opioid agonist with potent antinociceptive and weak rewarding effects in (2008) (50)
Chronic pain-induced astrocyte activation in the cingulate cortex with no change in neural or glial differentiation from neural stem cells in mice (2007) (50)
Possible Pharmacotherapy of the Opioid κ Receptor Agonist for Drug Dependence (2004) (49)
Prenatal and neonatal exposure to low-dose of bisphenol-A enhance the morphine-induced hyperlocomotion and rewarding effect (2006) (47)
Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ‐opioid‐induced place preference (2010) (46)
Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats (1997) (46)
Combined effects of psychostimulants and morphine on locomotor activity in mice. (2004) (46)
Suppression of enriched environment-induced neurogenesis in a rodent model of neuropathic pain (2008) (45)
Prenatal and neonatal exposure to bisphenol-A affects the morphine-induced rewarding effect and hyperlocomotion in mice (2004) (45)
Involvement of dopamine-dependent and -independent mechanisms in the rewarding effects mediated by δ opioid receptor subtypes in mice (1997) (44)
Differential activation of the μ‐opioid receptor by oxycodone and morphine in pain‐related brain regions in a bone cancer pain model (2013) (44)
Hippocampal epigenetic modification at the doublecortin gene is involved in the impairment of neurogenesis with aging (2010) (43)
Direct evidence for the involvement of endogenous β-endorphin in the suppression of the morphine-induced rewarding effect under a neuropathic pain-like state (2008) (42)
The role of dopamine D1-receptors in morphine-induced hyperlocomotion in mice (1994) (42)
Usefulness of Olanzapine as an Adjunct to Opioid Treatment and for the Treatment of Neuropathic Pain (2012) (41)
Blockade of δ-Opioid Receptors Prevents Morphine-Induced Place Preference in Mice (1994) (41)
Promoting effect of O-ethylmenthol on the percutaneous absorption of ketoprofen (1996) (39)
Effects of gabapentin on brain hyperactivity related to pain and sleep disturbance under a neuropathic pain‐like state using fMRI and brain wave analysis (2011) (39)
Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer (2012) (38)
Functional interaction among opioid receptor types: up-regulation of μ- and δ-opioid receptor functions after repeated stimulation of κ-opioid receptors (2004) (37)
Orally Active Opioid μ/δ Dual Agonist MGM-16, a Derivative of the Indole Alkaloid Mitragynine, Exhibits Potent Antiallodynic Effect on Neuropathic Pain in Mice (2014) (37)
Genistein, a Phytoestrogen, Attenuates Monocrotaline-Induced Pulmonary Hypertension (2006) (36)
PRECLINICAL STUDY: Changes in central dopaminergic systems and morphine reward by prenatal and neonatal exposure to bisphenol‐A in mice: evidence for the importance of exposure period (2007) (36)
Effect of a selective GABAB receptor agonist baclofen on the μ-opioid receptor agonist-induced antinociceptive, emetic and rewarding effects (2005) (36)
Possible involvement of mu1-opioid receptors in the fentanyl- or morphine-induced antinociception at supraspinal and spinal sites. (2002) (36)
The pharmacological profile of δ opioid receptor ligands, (+) and (−) TAN-67 on pain modulation (2001) (35)
The κ opioid system regulates endothelial cell differentiation and pathfinding in vascular development. (2011) (35)
Involvement of μ- and δ-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress (1998) (34)
Drug interactions in the reinforcing effects of over-the-counter cough syrups (2005) (34)
A putative sigma1 receptor antagonist NE‐100 attenuates the discriminative stimulus effects of ketamine in rats (2001) (33)
Modulation of κ-opioidergic systems on mecamylamine-precipitated nicotine-withdrawal aversion in rats (2002) (33)
Modification of morphine-induced locomotor activity by pertussis toxin: biochemical and behavioral studies in mice (1993) (33)
Behavioral sensitization to the discriminative stimulus effects of methamphetamine in rats. (2004) (33)
Effects of diabetes on spontaneous locomotor activity in mice (1994) (33)
Implication of cyclin‐dependent kinase 5 in the development of psychological dependence on and behavioral sensitization to morphine (2005) (32)
Intensification of the development of ethanol dependence in mice lacking dopamine D3 receptor (2002) (32)
Determination of tris(2-ethylhexyl)trimellitate released from PVC tube by LC-MS/MS. (2008) (31)
Functional changes in dopamine D3 receptors by prenatal and neonatal exposure to an endocrine disruptor bisphenol‐A in mice (2004) (31)
Involvement of spinal metabotropic glutamate receptor 5 in the development of tolerance to morphine‐induced antinociception (2005) (30)
Antitussive effects of naltrindole, a selective δ-opioid receptor antagonist, in mice and rats (1993) (30)
Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence. (2004) (30)
Effects of a selective κ-opioid agonist, U-50,488H, on morphine dependence in rats (1989) (29)
Molecular mechanism of changes in the morphine-induced pharmacological actions under chronic pain-like state: suppression of dopaminergic transmission in the brain. (2004) (29)
Changes in the rewarding effects induced by tramadol and its active metabolite M1 after sciatic nerve injury in mice (2008) (29)
Synthesis of a novel 6,14-epoxymorphinan derivative and its pharmacology. (2008) (29)
Methylxanthines (Caffeine and Theophylline) Blocked Methamphetamine‐induced Conditioned Place Preference in Mice but Enhanced That Induced by Cocaine (1992) (29)
The D3-receptor agonist (±)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice (1995) (29)
Post‐synaptic action of morphine on glutamatergic neuronal transmission related to the descending antinociceptive pathway in the rat thalamus (2007) (28)
Changes in G‐protein activity mediated through the stimulation of dopamine and GABA B receptors in the mesolimbic dopaminergic system of morphine‐sensitized mice (2003) (27)
Involvement of mGluR5 in the ethanol-induced neuropathic pain-like state in the rat (2006) (27)
Involvement of δ1 and δ2 Opioid Receptor Subtypes in the Development of Physical Dependence on Morphine in Mice (1997) (26)
Involvement of microglia in the ethanol-induced neuropathic pain-like state in the rat (2007) (26)
Antisense oligodeoxynucleotide to δ opioid receptors attenuates morphine dependence in mice (1997) (26)
Role of neuronal NR2B subunit‐containing NMDA receptor‐mediated Ca2+ influx and astrocytic activation in cultured mouse cortical neurons and astrocytes (2006) (26)
Involvement of dopamine D1 and D2 receptors in the ethanol-associated place preference in rats exposed to conditioned fear stress (1999) (26)
Involvement of δ-opioid receptors in the effects of morphine on locomotor activity and the mesolimbic dopaminergic system in mice (2005) (26)
In vitro and antinociceptive profile of HON0001, an orally active NMDA receptor NR2B subunit antagonist (2006) (26)
Ethanol, But Not the Anxiolytic Drugs Buspirone and Diazepam, Produces a Conditioned Place Preference in Rats Exposed to Conditioned Fear Stress (2000) (25)
Changes in function of NMDA receptor NR2B subunit in spinal cord of rats with neuropathy following chronic ethanol consumption. (2007) (25)
Hyperactivity in novel environment with increased dopamine and impaired novelty preference in apoptosis signal-regulating kinase 1 (ASK1)-deficient mice (2010) (25)
Differential properties between TRK-820 and U-50,488H on the discriminative stimulus effects in rats. (2004) (24)
Functional interaction among opioid receptor types: up-regulation of mu- and delta-opioid receptor functions after repeated stimulation of kappa-opioid receptors. (2004) (24)
NMDA receptor antagonists potently suppress the spontaneous withdrawal signs induced by discontinuation of long-term diazepam treatment in Fischer 344 rats (1998) (24)
Implication of Rho‐associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats (2003) (23)
Sensation of Abdominal Pain Induced by Peritoneal Carcinomatosis Is Accompanied by Changes in the Expression of Substance P and &mgr;-Opioid Receptors in the Spinal Cord of Mice (2012) (23)
Inhibitory effects of SA4503 on the rewarding effects of abused drugs (2014) (23)
Inhibition of the morphine-induced rewarding effect by direct activation of spinal protein kinase C in mice (2004) (23)
Possible involvement of μ 2-mediated mechanisms in μ-mediated antitussive activity in the mouse (1993) (23)
mGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumption. (2007) (23)
Differential mechanism of G-protein activation induced by endogenous mu-opioid peptides, endomorphin and beta-endorphin. (2002) (22)
Distinct Relations Among Plasma Concentrations Required for Different Pharmacological Effects in Oxycodone, Morphine, and Fentanyl (2011) (22)
PRECLINICAL STUDY: BRIEF REPORT: Epigenetic modulation at the CCR2 gene correlates with the maintenance of behavioral sensitization to methamphetamine (2010) (22)
Mechanism of opioid dependence and interaction between opioid receptors (2001) (22)
Possible involvement of prolonging spinal µ‐opioid receptor desensitization in the development of antihyperalgesic tolerance to µ‐opioids under a neuropathic pain‐like state (2013) (22)
Modulation of the decrease in the seizure threshold of pentylenetetrazole in diazepam withdrawn mice by the neurosteroid 5αpregnan‐3α,21‐diol‐20‐one (alloTHDOC) (1997) (21)
Implication of the descending dynorphinergic neuron projecting to the spinal cord in the (+)-matrine- and (+)-allomatrine-induced antinociceptive effects. (2005) (20)
Effects of μ-, δ- and κ-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice (2006) (20)
Increased phosphorylated-μ-opioid receptor immunoreactivity in the mouse spinal cord following sciatic nerve ligation (2004) (20)
Deltorphin II enhances extracellular levels of dopamine in the nucleus accumbens via opioid receptor-independent mechanisms. (2004) (20)
Treatment for psychological dependence on morphine: usefulness of inhibiting NMDA receptor and its associated protein kinase in the nucleus accumbens. (2005) (19)
G protein‐gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites (2014) (19)
Differences in the morphine-induced inhibition of small and large intestinal transit: Involvement of central and peripheral μ-opioid receptors in mice. (2016) (19)
Role of spinal voltage-dependent calcium channel α2δ-1 subunit in the expression of a neuropathic pain-like state in mice (2007) (19)
Characterization of methadone as a β-arrestin-biased μ-opioid receptor agonist (2016) (19)
Oxidative stress in methamphetamine-induced self-injurious behavior in mice (2007) (19)
Role of β-adrenoceptors in the expression of morphine withdrawal signs (1994) (19)
Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies. (2008) (19)
Baclofen as an Adjuvant Analgesic for Cancer Pain (2009) (19)
Differential modulation of μ-opioid receptor-mediated antitussive activity by δ-opioid receptor agonists in mice (1993) (18)
Comparison of the behavioral effects of bupropion and psychostimulants. (2013) (18)
Up-regulation of spinal μ-opioid receptor function to activate G-protein by chronic naloxone treatment (2001) (18)
Mice with neuropathic pain exhibit morphine tolerance due to a decrease in the morphine concentration in the brain. (2016) (18)
Involvement of δ1-opioid receptor antagonism in the antitussive effect of δ-opioid receptor antagonists (1994) (18)
Generalization of NMDA-receptor antagonists to the discriminative stimulus effects of kappa-opioid receptor agonists U-50,488H, but not TRK-820 in rats. (2006) (17)
Peripheral Opioid Antagonist Enhances the Effect of Anti-Tumor Drug by Blocking a Cell Growth-Suppressive Pathway In Vivo (2015) (17)
Oxycodone-Induced Analgesic Effects in a Bone Cancer Pain Model in Mice (2008) (17)
Disruption of the type 1 inositol 1,4,5-trisphosphate receptor gene suppresses the morphine-induced antinociception in the mouse (2003) (17)
Synthesis of novel twin drug consisting of 8-oxaendoethanotetrahydromorphides with a 1,4-dioxane spacer and its pharmacological activities: mu, kappa, and putative epsilon opioid receptor antagonists. (2009) (17)
Establishment of opioid-induced rewarding effects under oxaliplatin- and Paclitaxel-induced neuropathy in rats. (2014) (17)
Role of the NMDA receptor complex in DMCM‐induced seizure in mice (1997) (17)
Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice (2001) (16)
Effects of mirtazapine on sleep disturbance under neuropathic pain‐like state (2012) (16)
Implication of endogenous β-endorphin in the inhibition of the morphine-induced rewarding effect by the direct activation of spinal protein kinase C in mice (2008) (16)
Adrenalectomy potentiates the morphinebut not cocaine-induced place preference in rats (1995) (16)
Heterologous µ‐opioid receptor adaptation by repeated stimulation of κ‐opioid receptor: up‐regulation of G‐protein activation and antinociception (2003) (15)
Antisense oligodeoxynucleotide to δ opioid receptors blocks cocaine-induced place preference in mice (1997) (15)
Modulation of the discriminative stimulus effects of cocaine and methamphetamine by the histaminergic system. (2002) (15)
Reduced expression of a novel µ‐opioid receptor (MOR) subtype MOR‐1B in CXBK mice: Implications of MOR‐1B in the expression of MOR‐mediated responses (2003) (15)
Induction of c-fos expression in the mouse brain associated with hyperalgesia induced by intrathecal injection of protein kinase C activator (2004) (15)
Potentiation of pentazocine conditioned place preference by tripelennamine in rats (2006) (15)
Activation of central ATP-sensitive potassium channels produces the antinociception and spinal noradrenaline turnover-enhancing effect in mice (2005) (15)
Changes in Ca2+-dependent protein kinase C isoforms induced by chronic ethanol treatment in mice (2001) (15)
Role of μ- and δ-opioid receptors in the nucleus accumbens in turning behaviour of rats (2004) (15)
Sigma‐1 receptor function is critical for both the discriminative stimulus and aversive effects of the kappa‐opioid receptor agonist U‐50488H (2012) (15)
Direct evidence for the activation of phospholipase Cγ1 by in vivo treatment with morphine in the mouse periaqueductal gray matter (2003) (15)
Effect of cyclosporine A on the morphine-induced place preference (1993) (14)
Differential Substitution for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine and Methylphenidate in Rats (2014) (14)
Endomorphin-induced motivational effect: differential mechanism of endomorphin-1 and endomorphin-2. (2002) (14)
Morphine and oxycodone, but not fentanyl, exhibit antinociceptive effects mediated by G-protein inwardly rectifying potassium (GIRK) channels in an oxaliplatin-induced neuropathy rat model (2014) (14)
Lack of development of behavioral sensitization to methylphenidate in mice: correlation with reversible astrocytic activation. (2007) (13)
Lack of the involvement of μ1-opioid receptor subtype on motivational effects induced by the endogenous μ-opioid receptor ligands endomorphin-1 and -2 in the mouse (2001) (13)
An ATP-sensitive potassium channel blocker abolishes the potentiating effect of morphine on the bicuculline-induced convulsion in mice (2005) (13)
Effect of chronic ethanol treatment on μ-opioid receptor function, interacting proteins and morphine-induced place preference (2013) (13)
The contribution of Gi/o protein to opioid antinociception in an oxaliplatin-induced neuropathy rat model. (2014) (13)
Discriminative stimulus effects of hallucinogenic drugs: a possible relation to reinforcing and aversive effects. (2012) (12)
Pharmacological profile of TAN‐452, a novel peripherally acting opioid receptor antagonist for the treatment of opioid‐induced bowel syndromes (2018) (12)
Enhanced GABAergic synaptic transmission at VLPAG neurons and potent modulation by oxycodone in a bone cancer pain model (2015) (12)
Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice. (2003) (12)
Effects of mu-, delta- and kappa-opioid receptor agonists on methamphetamine-induced self-injurious behavior in mice. (2006) (12)
Involvement of serotonin receptor mechanisms in the discriminative stimulus effects of ketamine in rats. (2013) (12)
Recent Advances in the Search for the -Opioidergic System (2002) (11)
Changes in central dopaminergic systems with the expression of Shh or GDNF in mice perinatally exposed to bisphenol-A. (2007) (11)
Usefulness of the dopamine system-stabilizer aripiprazole for reducing morphine-induced emesis. (2007) (11)
The kappa opioid receptor agonist SA14867 has antinociceptive and weak sedative effects in models of acute and chronic pain. (2011) (11)
Effects of serotonergic anxiolytics on physical dependence on diazepam in mice (1993) (11)
Antagonism of the morphine-induced Straub tail reaction by κ-opioid receptor activation in mice (2005) (11)
Chronic morphine treatment increases the expression of vesicular glutamate transporter 1 in the mouse spinal cord. (2006) (10)
Role of actin depolymerizing factor in the development of methamphetamine-induced place preference in mice. (2011) (10)
Reduction in ATP-sensitive potassium channel-mediated antinociception in diabetic mice (2005) (10)
Activation of extracellular signal‐regulated kinase is critical for the discriminative stimulus effects induced by U‐50,488H (2011) (10)
The effects of cyclosporine on morphine-induced antinociception in diabetic mice (1993) (10)
Different effects of NMDA/group I metabotropic glutamate receptor agents in δ- and μ-opioid receptor agonist-induced supraspinal antinociception (2000) (10)
Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer. (2008) (10)
A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting (2020) (10)
Chronic morphine treatment increases the expression of the neural cell adhesion molecule in the dorsal horn of the mouse spinal cord (2006) (10)
[Exposure to bisphenol-A affects the rewarding system in mice]. (2005) (10)
Involvement of the K+‐Cl− co‐transporter KCC2 in the sensitization to morphine‐induced hyperlocomotion under chronic treatment with zolpidem in the mesolimbic system (2013) (10)
Differences in tolerance to anti-hyperalgesic effects between chronic treatment with morphine and fentanyl under a state of pain. (2006) (10)
Actin dynamics in development of behavioral sensitization after withdrawal from long-term ethanol administration to mice. (2012) (9)
[Role of astrocytes in rewarding effects of drugs of abuse]. (2006) (9)
Influence of a deletion of protein kinase Cγ isoform in the G-protein activation mediated through opioid receptor-like-1 and μ-opioid receptors in the mouse pons/medulla (2002) (9)
Direct Evidence for the Ongoing Brain Activation by Enhanced Dynorphinergic System in the Spinal Cord under Inflammatory Noxious Stimuli (2010) (9)
Enhancement of glutamatergic transmission in the cingulate cortex in response to mild noxious stimuli under a neuropathic pain‐like state (2011) (9)
Region-specific changes in [3H]dizocilpine binding in diazepam-withdrawn rats (1998) (9)
Involvement of supraspinal and peripheral naloxonazine-insensitive opioid receptor sites in the expression of μ-opioid receptor agonist-induced physical dependence. (2013) (9)
Changes in the melanocortin receptors in the hypothalamus of a rat model of cancer cachexia (2012) (9)
Enhancement of dopamine-induced signaling responses in the forebrain of mice lacking dopamine D3 receptor (2004) (9)
Cell-dependent physiological synaptic action of morphine in the rat habenular nucleus: Morphine both inhibits and facilitates excitatory synaptic transmission (2009) (9)
Implications of Ca2+-activated Cl− channels in the δ-opioid receptor-mediated antinociception in the mouse spinal cord (2000) (9)
Sleep disturbance associated with an enhanced orexinergic system induced by chronic treatment with paroxetine and milnacipran (2011) (9)
[The analysis of prescription frequency and the factors on adverse reactions of NSAIDs for post-operative pain in orthopedic patients]. (2003) (8)
Role of dopamine D2 and D3 receptors in mediating the U‐50,488H discriminative cue: comparison with methamphetamine and cocaine (2012) (8)
Role of central ATP-sensitive potassium channels in the hyperthermic effect of morphine in mice (2005) (8)
Role of Src family kinase in the rewarding effect and hyperlocomotion induced by morphine (2006) (8)
Effects of (+)‐pentazocine on the antinociceptive effects of (–)‐pentazocine in mice (2015) (8)
Role of gap junction in the expression of morphine-induced antinociception. (2006) (8)
Implication of spinal protein kinase Cγ isoform in activation of the mouse brain by intrathecal injection of the protein kinase C activator phorbol 12,13-dibutyrate using functional magnetic resonance imaging analysis (2008) (8)
Effect of pretreatment with pertussis toxin on the development of physical dependence on morphine (1993) (8)
Involvement of the arachidonic acid cascade in the hypersusceptibility to pentylenetetrazole-induced seizure during diazepam withdrawal. (2012) (8)
Upregulation of bradykinin receptors is implicated in the pain associated with caerulein‐induced acute pancreatitis (2011) (8)
Preference for cocaine by the weight pulling method in rats (1990) (8)
Involvement of histaminergic system in the discriminative stimulus effects of morphine. (2004) (8)
Agonist and antagonist properties of dihydroetorphine for μ-opioid receptors in mice (1996) (7)
Effects of Prenatal and Neonatal Exposure to Bisphenol A on the Development of the Central Nervous System (2010) (7)
Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT (2016) (7)
Antitussive effects of μ- and κ-agonists in diabetic rats (1993) (7)
Olanzapine suppresses the rewarding and discriminative stimulus effects induced by morphine (2012) (7)
Role of spinal voltage-dependent calcium channel alpha 2 delta-1 subunit in the expression of a neuropathic pain-like state in mice. (2007) (7)
μ-Opioid receptor-independent fashion of the suppression of sodium currents by μ-opioid analgesics in thalamic neurons (2009) (7)
Effects of flunarizine and diltiazem on physical dependence on barbital in rats (1993) (7)
[Differences in neuronal toxicity and its molecular mechanisms between methamphetamine and methylphenidate]. (2009) (6)
Implication of Src family kinase-dependent phosphorylation of NR2B subunit-containing NMDA receptor in the rewarding effect of morphine. (2006) (6)
Subdiaphragmatic vagotomy increases the sensitivity of lumbar Aδ primary afferent neurons along with voltage‐dependent potassium channels in rats (2012) (6)
Preventive effects of naldemedine, peripherally acting μ-opioid receptor antagonist, on morphine-induced nausea and vomiting in ferrets. (2020) (5)
Effects of dronabinol on morphine‐induced dopamine‐related behavioral effects in animals (2012) (5)
Delta Opioid Receptor–Mediated Antinociception/ Analgesia (2003) (5)
Involvement of μ‐ and δ‐opioid receptor function in the rewarding effect of (±)‐pentazocine (2015) (5)
Effect of p-chlorophenylalanine on diazepam withdrawal signs in rats (2004) (5)
Region-dependent G-protein activation by κ-opioid receptor agonists in the mouse brain (2004) (5)
Role of mu- and delta-opioid receptors in the nucleus accumbens in turning behaviour of rats. (2004) (5)
Interaction between mu and kappa receptors in pharmacological effects of tolerance to and dependence on several opioids (1990) (4)
Genetic background influences nicotine-induced conditioned place preference and place aversion in mice. (2014) (4)
Enhancement of the rewarding effects of 3,4-methylenedioxymethamphetamine in orexin knockout mice (2020) (4)
The Discriminative Stimulus Properties of Hallucinogenic and Dissociative Anesthetic Drugs. (2016) (4)
Brain site- and transmitter-dependent actions of methamphetamine, morphine and antipsychotics (2016) (4)
Direct evidence for the up‐regulation of spinal µ‐opioid receptor function after repeated stimulation of κ‐opioid receptors in the mouse (2003) (4)
[Difference in tolerance to anti-hyperalgesic effect and its molecular mechanisms between chronic treatment with morphine, fentanyl and oxycodone in a chronic pain-like state]. (2008) (4)
[Combined spinal-epidural anesthesia for cesarean section in a patient with dilated cardiomyopathy]. (2008) (4)
Involvement of dopamine D2 receptor signal transduction in the discriminative stimulus effects of the &kgr;-opioid receptor agonist U-50,488H in rats (2013) (4)
Implication of KCC2 in the sensitization to morphine by chronic ethanol treatment in mice (2014) (4)
Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice. (2013) (3)
Implication of mGlu5 receptor in the enhancement of morphine-induced hyperlocomotion under chronic treatment with zolpidem. (2014) (3)
Direct evidence for the up-regulation of spinal micro-opioid receptor function after repeated stimulation of kappa-opioid receptors in the mouse. (2003) (3)
Up-regulation of μ-opioid receptor-mediated G-protein activation in protein kinase Cγ knockout mice following repeated naloxone treatment (2003) (3)
Corrigendum to ‘Antinociceptive effects of the selective non-peptide δ-opioid receptor agonist TAN-67 in diabetic mice’ [Eur. J. Pharmacol. 276 (1995) 131–135] (1995) (3)
Subdiaphragmatic vagotomy induces a functional change in visceral Aδ primary afferent fibers in rats (2012) (3)
[Behavioral analysis of chronic exposure to diphenylarsinic and associated influence on central nervous systems]. (2007) (3)
Possible involvement of β‐endorphin in a loss of the coordinated balance of μ‐opioid receptors trafficking processes by fentanyl (2011) (3)
[Psychological stress and rewarding effect of alcohol]. (2002) (3)
Preferences for opioids by the weight pulling method in rats (1990) (3)
Rewarding effects of ethanol combined with low doses of morphine through dopamine D1 receptors. (2013) (3)
Involvement of 5-HT2 receptors in the expression of withdrawal diarrhea in morphine-dependent mice. (2014) (3)
Role of tyrosine kinase-dependent phosphorylation of NR2B subunit-containing NMDA receptor in morphine reward. (2007) (2)
Induction of physical dependence on pentobarbital by new infusion method in the rat (1989) (2)
Chronic Pain Stimuli Downregulate Mesolimbic Dopaminergic Transmission: Possible Mechanism of the Suppression of Opioid Reward (2014) (2)
INDUCTION OF PHYSICAL DEPENDENCE IN RATS BY SHORT TREATMENT OF MORPHINE-ADMIXED FOOD (1981) (2)
Role of Inhibins and Activins in Reproduction (1993) (2)
β-Funaltrexamine Discriminates between Two Subtypes of μ2-Opioid Receptors in Electrically Stimulated Longitudinal Muscle of Guinea Pig Ileum (1998) (2)
[Effects of fasudil on neuropathic pain-like state in mice]. (2007) (2)
Enhanced m-Opioid Responses in the Spinal Cord of Mice Lacking Protein Kinase Cg Isoform* (2001) (2)
TRK-820 , a Selective-Opioid Agonist , Produces Potent Antinociception in Cynomolgus Monkeys (2001) (2)
Comparison of Anti-Nociceptive and Anti-Inflammatory/Analgesic Effects of Essential Oils in Experimental Animal Models (2014) (2)
Physical dependence on diazepam in Lewis and Fischer 344 inbred rat strains (1990) (2)
Region-dependent G-protein activation by kappa-opioid receptor agonists in the mouse brain. (2004) (2)
[Treatment of Cancer Pain and Medical Narcotics]. (2015) (2)
Effects of histaminergic drugs on development of analgesic tolerance to morphine in mice (1992) (1)
[Substance related disorders and addictive disorders]. (2014) (1)
Comparative pharmacological profiles of oxycodone and morphine in a neuropathic pain-like state in mice (2007) (1)
BEHAVIORAL CHANGES IN MORPHINE-TOLERANT MICE (1982) (1)
[Survey on patients' satisfaction with opioid rescue guidance by pharmacists]. (2008) (1)
Involvement of the Peripheral μ-Opioid Receptor in Tramadol-Induced Constipation in Rodents. (2021) (1)
Splenectomy modifies hyperactive states of the dopaminergic system induced by morphine in C57BL/6J-bg(J)/bg(J) (beige-J) mice. (2014) (1)
A new opioid analgesic KT90: Analgesia and dependence liability (1990) (1)
Diazepam oral self-administration in Lewis and Ficher 344 inbred rat strains (1990) (1)
G Protein Activation by Endomorphins in the Mouse Periaqueductal Gray Matter (2000) (1)
[Evaluation method for a pain-like action]. (2007) (1)
Involvement of spinal G-protein inwardly rectifying potassium (GIRK) channels in the enhanced antinociceptive effects of the activation of both μ-opioid and cannabinoid CB1 receptors. (2022) (1)
COMPARISON OF PHARMACOLOGICAL PROPERTIES BETWEEN PENTAZOCINE AND HOMOBENZOMORPHAN DERIVATIVES (1981) (1)
P-44INVOLVEMENT OF MU- AND DELTA-OPIOID RECEPTOR FUNCTION IN THE REWARDING EFFECT OF PENTAZOCINE (2014) (1)
Dopaminergic hyperactivity accompanied by hyperlocomotion in C57BL/6J-bg(J)/bg(J) (beige-J) mice. (2014) (1)
The astrocyte-targeted therapy by Bushi for the neuropathic pain (2011) (0)
Studies on drug dependence (Kept. 135): Sex differences in physical dependence on methaqualone in the rat (1987) (0)
P-II-A-7 Caffeine's (CAF) Effect on Methamphetamine (MAP), Cocaine (CAN), Morphine(MRP) and Pentobarbital(PTB)-induced Conditioned Place Preference in Mice. 日本動物心理学会第51回大会発表要旨 (1991) (0)
Synergistic effects of MDMA and ethanol on behavior: Possible effects of ethanol on dopamine D2‐receptor‐related signaling (2020) (0)
Studies on drug dependence (Rept.100): A study on the quantitative evaluation of drug-seeking behavior for codeine in rats by the weight-pulling method (1983) (0)
Effects of lipopolysaccharides on dopamine-related behavior of methamphetamine (2014) (0)
Quantitative trait loci analysis of morphine-induced psychological dependence (2008) (0)
The advantages of fentanyl for the treatment of pain: Studies of pharmacological profiles and fentanyl relatedside effects (2005) (0)
Drug against drug addiction (1999) (0)
Analysis of molecular mechanism underlying the control of ES cell differentiation by the stimulation of dopamine receptors located on embryonic stem cells (2010) (0)
Studies on drug dependence (Rept. 101): Specificity of the biochemical changes induced by barbital withdrawal (1983) (0)
[The implication of protein kinase C in the cell-cell interaction during the development of dependence on morphine]. (2006) (0)
Studies on drug dependence (Rept. 284) : Role of endogenous opioid system in cthanol-induced place preference under foot shock stress in rats (1997) (0)
Modification of Morphine Dependence under Chronic Pain and Its Mechanism (2002) (0)
Role of G-protein coupled receptors in the neural differentiation from embryonic stem cells (2010) (0)
The role of GABAA receptors on ethanol-induced type 1 IP3 receptor up-regulation (2015) (0)
Chronic pain induces the changes in glial function associated with emotional dysfunction (2007) (0)
New psychotropic substance abuse and its regulation. (2017) (0)
STUDIES ON DRUG DEPENDENCE (REPT. 52) INDUCTION OF MORPHINE DEPENDENT MICE BY DAF (DRUG-ADMIXED FOOD) METHOD (1980) (0)
P-26CHANGE IN ALDEHYDE DEHYDROGENASE BY CHRONIC TREATMENT WITH ETHANOL IN THE MOUSE BRAIN (2014) (0)
Psychological dependence on opioid analgesics. (2013) (0)
[Electrophysiological technique--significance as an experimental method for alcoholic study]. (2008) (0)
Studies on pain control system (Rept. 107): Possible role of the spinal IL-6/C-C chemokine-mediated signaling network in the development of a neuropathic pain-like state in mice (2009) (0)
Studies on drug dependence (Rept.345): Role of protein kinase Cγ isoform in desensitization of G-protein activation by μ-opioid receptor agonist (2000) (0)
S9-4 Molecular mechanism of changes in the morphine-induced rewarding effect under chronic pain-like state : Suppression of dopaminergic transmission in the brain(SYMPOSIUM 9: MOLECULAR MECHANISMS OF DRUG DEPENDENCE)(Proceedings of the 31st Annual Meeting) (2004) (0)
The effect of chronic treatment with naltrindole, a selective δ-opioid antagonist, on μ-opioid receptor-mediated antinociception in diabetic mice (2005) (0)
Pain clinic and drugs of abuse (2005) (0)
Studies on drug dependence (Rept. 159): Genetic analysis of reverse tolerances to several drugs in two strains of inbred mice (1989) (0)
P-II-5 The Effect of Methamphetamine and Caffeine on Place Preference Conditioning(日本動物心理学会第50回大会発表) (1990) (0)
[Physiological functions of sigma-1 receptors and its relation to psychic dependence]. (2012) (0)
Clinical Pharmacokinetics of Methadone (2014) (0)
Enhancement of benzodiazepines on abused drug-induced hyperlocomotion (2014) (0)
Studies on drug dependence (Rept. 228): Pharmacogenetic analysis of morphine-induced locomotor activity in SMXA mice. (1993) (0)
The analgesic effect of Bushimatsu via inhibition of astrocytic activaion on neuropathic pain (2010) (0)
Studies on drug dependence (Rept. 300): Role of NMDA receptor in the appearance of diazepam withdrawal signs (1998) (0)
[Basic studies on cancer pain control]. (2005) (0)
STUDIES ON DRUG DEPENDENCE (REPT. 90) TOLERANCE TO METHAMPHETAMINE AND EFFECT OF COMBINATION OF METHAMPHETAMINE AND QUININE (1982) (0)
Effect of chronic ethanol treatment on μ-opioid receptor function, interacting proteins and morphine-induced place preference (2013) (0)
Chronic treatment with diphenylarsinic acid (DPAA) affects central nerves system(Proceedings of the 32nd Annual Meeting) (2005) (0)
Proper use of opioid analgesic (2006) (0)
of the sciatic nerve by the partial ligation (2000) (0)
Changes in brain dynamics by chronic pain: Molecular mechanisms of the suppression of morphine-induced rewarding effects and the aggravated anxiety (2006) (0)
Correction: Multiple Analyses of G-Protein Coupled Receptor (GPCR) Expression in the Development of Gefitinib-Resistance in Transforming Non-Small-Cell Lung Cancer (2013) (0)
Studies on drug dependence (Rept. 342): Down-regulation of μ-opioid receptor expression is necessary for the suppression of the morphine-induced sensitization by rolipram (2000) (0)
Role of spinal thrombin and platelet-derived growth factor in the expression of chronic pain-like state in mice (2007) (0)
Studies on drug dependence (Rept. 211): Establishment of ethanol-induced place preference in rats (1992) (0)
Study on drug dependence (Rept. 381) : Direct evidence for the up-regulation of central μ-opioid receptor functions induced by repeated stimulation of κ-opioid receptors (2003) (0)
Remedies for neuropathic pain animal models of neuropathic pain. (2000) (0)
Studies on pain control system (Rept. 67): Opioids regulate sodium currents in rat cultured thalamic neurons (2007) (0)
Analysis of sleep disturbance associated with the change in nerve function in the cingulate cortex under neuropathic pain (2011) (0)
P1–015ACTIONS OF THE SYMPTOM CONTROL RESEARCH GROUP (SCORE-G) IN THE PALLIATIVE CARE FIELD IN JAPAN: REPORT 3 (2013) (0)
Chronic ethanol treatment alters the central gene-expression profiling along with epigenetic modifications (2010) (0)
Studies on pain control system (Rept.106): Vagal dysfunction caused nociceptive neuroplasticity (2009) (0)
Studies on drug dependence (Rept. 323): Changes in methamphetamine (MAP)-induced place preference and discrimination in rats pretreated with MAP. (1999) (0)
STUDIES ON DRUG DEPENDENCE (REPT. 72) BRAIN MORPHINE LEVELS OF DEPENDENT MICE BY DAF (DRUG-ADMIXED FOOD) METHOD (1981) (0)
Studies on drug dependence (Rept. 210): Enhancing effects of opioids and antihistamines on psychostimulants-induced place preference in rats (1992) (0)
Studies on drug dependence (Rept. 322): Attenuation of morphine- and psychostimulants-induced place preference by α1 receptor agonist SA4503. (1999) (0)
Promotion of the neural differentiation from embryonic stem cells activated by dopamine D3 receptors (2009) (0)
Molecular mechanism underlying the suppression of the morphine-induced rewarding effect and reduced sensitivity to morphine-induced antinociceptive action under chronic pain-like state (2004) (0)
Erratum to “Differential involvement of spinal protein kinase C and protein kinase A in neuropathic and inflammatory pain in mice” [Brain Res. 992 (2003) 288–293] (2004) (0)
Studies on drug dependence (Rept. 260): Anticonflict action of U50.488H (1995) (0)
Studies on drug dependence (Report 99): Effect of quinine on methamphetamine-induced stereotyped behavior and acute toxicity in rats (1983) (0)
Studies on pain control system (Rept. 120): Multiplex gene profiling with epigenetic modification in the spinal cord of mice with neuropathic pain (2010) (0)
[Implication of neuron-glia interaction in the molecular mechanism of drug dependence]. (2008) (0)
Drug delivery system in pain control Pharmacological characteristics of narcotics (2005) (0)
[Implication of glial function in the development of drug dependence associated with synaptic plasticity]. (2005) (0)
Cure for drug addiction (1998) (0)
Effects of imipramine on physical dependence on barbital in rats (1993) (0)
Molecular mechanisms underlying the reduced opioid reward assosiated with alteration of microRNA expression and epigenetic modulation under the neuropathic pain (2010) (0)
The K + -Cl − Cotransporter KCC2 and Zolpidem (2016) (0)
Studies on drug dependence (Rept. 122): Degree of physical dependence induced by pentobarbital and pentobarbital sodium (1985) (0)
P-46depletion of orexin affects the discriminative stimulus and rewarding effects of mdma in mice. (2014) (0)
ATPによる自然”グリオトランスミッションは”培養海馬星状細胞において細胞内シグナリングカスケードのスイッチングオーバーを起こす (2004) (0)
Studies on pain control system (Rept. 66): Involvement of endogenous opioidergic system in the suppression of the morphine-induced rewarding effect under the neuropathic pain-like state (2007) (0)
Narcolepsy-like sleep disturbance in orexin knockout mice are normalized by the 5-HT1A receptor agonist 8-OH-DPAT (2016) (0)
Remedy for neuropathic pain and laboratory animal-models of neuropathic pain (2000) (0)
Studies on drug dependence (Rept. 274): The role of κ-opioid receptor in morphine-induced place preference under inflammations. (1996) (0)
Genetic background influences the change from the discriminative stimulus to the rewarding effects of psychostimulants in rats (2015) (0)
Involvement of mGlu5 receptor signal cascade in the enhancement of morphine-induced hyperlocomotion under chronic treatment with zolpidem (2015) (0)
Changes in new generation of glial cells under the neuropathic pain like state (2007) (0)
1365 – EVALUATION OF INDUCING PHYSICAL DEPENDENCE AND PROMOTING SPONTANEOUS DRUG INTAKE IN CHOICE TRIALS USING DRUG-ADMIXED DIET IN RATS (1977) (0)
Possible implication of μ-opioid receptors in the neural differentiation from embryonic stem cells (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Tsutomu Suzuki?

Tsutomu Suzuki is affiliated with the following schools:

Tsutomu Suzuki's Academic­Influence.com Rankings